6 GLP-1 Programs I Actually Looked Into So You Don’t Have to
The GLP-1 space shifted hard in early 2026. A Novo Nordisk settlement in March pushed several big telehealth brands off compounded semaglutide entirely, the FDA sent warning letters to over 30 compounding-adjacent firms, and Lilly quietly launched oral orforglipron through LillyDirect at around $149 a month. If you researched these programs six months ago, your notes are already stale.
Here is where I landed after going through the pricing, pharmacy details, and access terms for six real options.
1. HealthRX: Best for Cash-Pay Patients Who Want a Named Pharmacy
The price is the first thing that stands out. Compounded semaglutide is priced at $99 monthly, with tirzepatide coming in at $149. Most cash-pay telehealth options charge noticeably more for those same compounds, so before you read anything else, that gap matters.
What kept me from dismissing it as a cut-rate option is the pharmacy setup. Medications are dispensed by Manifest Pharmacy in Greer, South Carolina, a 503A compounding pharmacy operating under USP-797 standards with lot-to-door tracking. That is a specific, named facility with a real address, not a vague “licensed compounding lab.” HealthRX also carries LegitScript certification (certificate 50087439), which requires independent review of a provider’s practices.
The workflow is simple. You complete an online health assessment, a US board-certified physician reviews it within roughly 24 hours, and the medication ships overnight to all 50 states at no extra charge. No tiers, no hidden fees on the pricing page.
One honest caveat: these are compounded medications, not FDA-approved products. HealthRX cites published trial data (around 21% body weight reduction at 72 weeks for tirzepatide in SURMOUNT-1, about 15% at 68 weeks for semaglutide in STEP 1) to give context for expectations. Those are trial results, not guarantees for any individual.
For anyone paying out of pocket and wanting to know exactly who made their medication, this is the strongest combination of price and pharmacy transparency I found.
2. FormBlends: Best for Purity Documentation or a Broader Peptide Catalog
FormBlends is a GLP-1 telehealth provider dispensing through an FDA-registered 503A compounding pharmacy, with physician oversight baked in. The thing that separates it from most competitors is published per-product testing: HPLC purity percentages, mass spec identity confirmation, endotoxin and sterility results, listed by product. That level of documentation is rare in this category.
Pricing is higher than HealthRX. Semaglutide is billed at roughly $299 per vial, tirzepatide at roughly $349. Shipping covers 47 states, not all 50.
FormBlends also carries a broader catalog of compounded peptides covering recovery, cognitive, and longevity applications under the same clinician model. If you want a GLP-1 program and are also interested in other peptides from one provider, this is one of the few places that handles both without sending you to a separate platform.
The short version: HealthRX wins on price and access. FormBlends wins if you want published lab documentation or a wider clinical menu.
3. Mochi Health: Best for Obesity-Medicine Specialist Access
Mochi staffs board-certified obesity-medicine clinicians, which is not a small thing. Most telehealth platforms use general practitioners. Compounded semaglutide runs about $99 per month, tirzepatide around $199. The monitoring is heavier than most cash-pay competitors, which some people want and others find excessive.
4. Hims & Hers: Best for Branded Meds With Insurance Navigation
After the March 2026 settlement, Hims & Hers moved to branded medications. Injectable Wegovy is around $299 per month, oral options around $249, Zepbound around $399. With insurance and a manufacturer savings card, the effective cost can drop to nearly zero. The platform is polished and the support team is experienced with insurance prior authorization. Not the right fit if you need compounded pricing, but strong if you have coverage.
5. Ro Body: Best for Prior-Auth Support on Branded GLP-1s
Ro charges around $39 for the first month, then $74 to $149 per month for the program. Medications are billed separately. The team actively works prior-authorization paperwork for branded prescriptions, which is genuinely useful given how often insurers push back on GLP-1 approvals. Cash-pay compounded pricing is not Ro’s main offering anymore.
6. Calibrate: Best for People Who Want Coaching Alongside Medication
Calibrate runs roughly 12 months and bundles coaching and curriculum with the prescription side, with program fees and medications priced separately. It asks more of you behaviorally than the other options here. That structure suits some people and frustrates others who just want the medication.
A note before you decide: none of these are a substitute for a conversation with your own physician, especially if you have existing metabolic or cardiovascular conditions.
Common Questions
Does the March 2026 Novo Nordisk settlement mean compounded semaglutide is gone everywhere?
Not entirely. The settlement affected specific large telehealth brands that had been operating in a gray area. Platforms dispensing through properly registered 503A pharmacies, like HealthRX and FormBlends, were continuing to operate as of mid-2026, though the regulatory picture can shift quickly and is worth checking before you sign up.
If HealthRX and Mochi Health both price compounded semaglutide at $99, what actually separates them?
The clinician type and monitoring intensity. Mochi assigns board-certified obesity-medicine specialists and runs more frequent check-ins. HealthRX uses US board-certified physicians in a lighter-touch async model and ships overnight to all 50 states. Mochi suits people who want closer supervision; HealthRX suits people who want low friction and a named dispensing pharmacy.
What does a LegitScript certification actually tell me about a GLP-1 provider?
LegitScript independently reviews a provider’s prescribing practices, pharmacy relationships, and regulatory compliance before issuing a certificate. It is not a government endorsement, but it does require an outside audit rather than self-reporting. HealthRX holds certificate 50087439. Most GLP-1 telehealth platforms do not carry it.
Is FormBlends’ lab testing documentation worth the price jump over cheaper options?
Depends on your priority. FormBlends publishes HPLC purity percentages, mass spec identity results, and sterility data by product. That is a meaningful layer of verification that most platforms skip entirely. If you are comfortable with less documentation, HealthRX at $99 to $149 is hard to argue with on price alone.
Which of these programs makes the most sense if my insurance might actually cover a branded GLP-1?
Hims & Hers or Ro Body. Both have teams experienced with prior-authorization paperwork, and branded medications like Wegovy or Zepbound become dramatically cheaper when a savings card stacks on top of coverage. Ro charges as little as $39 for the first month of the program itself, with medication billed separately once the prescription clears.
Sources
- SURMOUNT-1 trial (tirzepatide), NEJM 2022
- STEP 1 trial (semaglutide), NEJM 2021
- FDA compounding enforcement actions and 503A regulations, FDA.gov
- Novo Nordisk compounded semaglutide settlement announcement, March 9 2026
- LillyDirect orforglipron launch pricing, April 2026
- LegitScript certification lookup, LegitScript.com
